Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
Department of Health and Human Services
The purpose of this announcement is to encourage investigators to pursue translational activities and clinical feasibility studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities, obtaining an Investigational Device Exemption (IDE) for a Significant Risk (SR) study or Institutional Review Board (IRB) approval for a Non-Significant Risk (NSR) study, as well as a subsequent clinical feasibility study. The clinical study is expected to pr
Funding
Award size
Not specified
Type
Cooperative Agreement
Dates
Deadline
Later
Posted
06/17/2025
Closes
2028-01-28
Eligibility
Eligibility
City or township governmentsOthers (see text field entitled "Additional Information on Eligibility" for clarification)Small businessesIndependent school districtsNative American tribal governments (Federally recognized)State governmentsSpecial district governmentsNative American tribal organizations (other than Federally recognized tribal governments)County governmentsPrivate institutions of higher educationFor profit organizations other than small businessesNonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationPublic and State controlled institutions of higher educationPublic housing authorities/Indian housing authoritiesNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Program
Funding area
Education - EDHealth - HLIncome Security and Social Services - ISS
Opportunity #
PAR-25-383
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov